Skip to main content

EASD: Factors Linked to Lower-Limb Amputation ID'd in Diabetes

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

WEDNESDAY, Aug. 23, 2023 -- For people with newly diagnosed diabetes, the risk for lower-limb amputation (LLA) is increased for those with older age, males, and divorced individuals, according to a study to be presented at the annual meeting of the European Association for the Study of Diabetes, being held Oct. 2 to 6 in Hamburg, Germany.

Stefan Jansson, Ph.D., from Örebro University in Sweden, and colleagues examined the association of demographic, socioeconomic, medical, and lifestyle risk factors with LLA in people with newly diagnosed diabetes using Swedish national register-linked data. The cohort consisted of 66,569 individuals aged 18 years or older with an incident diabetes diagnosis.

There were 133 LLAs during the median follow-up of four years. The researchers found that in a model mutually adjusting for all variables, positive associations were seen for higher age (hazard ratio [HR], 1.08 per year), being divorced versus married (HR, 1.67), and male sex (HR, 1.57). Compared with those with healthy feet, those with an increased foot risk at baseline had an increased risk for LLA (HR, 4.12, 8.26, and 11.24 for neuropathy/angiopathy, previous wounds, and ongoing severe foot disease, respectively). Compared with diet-only treatment, insulin treatment had an HR of 2.03. A significantly lower risk was seen for people with obesity versus those with normal weight (HR, 0.46). Compared with no smoking, smoking was associated with increased risk (HR, 1.99). Relative to daily physical activity, low physical activity (less than one time/week) was associated with increased risk (HR, 2.05).

"Lifestyle variables have a strong association with LLA, and an increase in physical activity, avoidance of being underweight, and smoking cessation may be impactful interventions to reduce the risk of LLA," the authors said in a statement.

Abstract

More Information

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

Semaglutide Cuts Risk for Kidney Outcomes, Death in CKD With T2DM

FRIDAY, May 31, 2024 -- For patients with type 2 diabetes and chronic kidney disease, semaglutide reduces the risk for clinically important kidney outcomes and death from...

Demographic, Clinical, Financial Factors Tied to GLP-1 Agonist Discontinuation

WEDNESDAY, May 29, 2024 -- Specific demographic, clinical, and financial characteristics are associated with glucagon-like peptide 1 (GLP-1) receptor agonist discontinuation...

GLP-1 Receptor Agonist Dispensing Up From 2020 to 2023 for Teens, Young Adults

WEDNESDAY, May 22, 2024 -- For adolescents and young adults, glucagon-like peptide-1 receptor agonist (GLP-1 RA) dispensing increased from 2020 to 2023, according to a research...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.